MBio Diagnostics

MBio is leading a new era in rapid, on-the-spot clinical diagnostics and sample testing. Our portable MBio multiplex analyzer and disposable cartridge enable low-cost, rapid answers in 1 to 20 minutes. MBio aims to be the platform of choice for leading providers and users of clinical and analytical testing services in all market segments including: medical, veterinary, environmental, food, agricultural and military. With a broad patent portfolio backed by over 8 years of development expertise and milestones, MBio’s platform has been validated through multiple partnerships with industry, academia and government. We are proud of our many scientific publications supporting our company and the MBio Array System. Our patented LightDeck® technology does not require sample prep and can be designed to detect all key analytes including proteins, cells, nucleic acids and small molecules.
Type
Private
HQ
Boulder, US
Founded
2009
Employees
17 (est)-10%
MBio Diagnostics was founded in 2009 and is headquartered in Boulder, US

Key People at MBio Diagnostics

Michael J. Lochhead

Michael J. Lochhead

Vice President
Sarah Hatcher

Sarah Hatcher

President and Counsel
Christopher J. Myatt

Christopher J. Myatt

Founder and Chief Executive Officer

MBio Diagnostics Locations

Boulder, US

MBio Diagnostics Metrics

MBio Diagnostics Summary

Founding Date

2009

Total Funding

$8.3 M

Latest funding size

$6.3 M

Time since last funding

over 1 year
MBio Diagnostics's latest funding round of $6.3 M was in May 2015. In total, MBio Diagnostics has raised $8.3 M.
29% of current employees of MBio Diagnostics are female and 71% are male.

Market Position – Health, clinics, diagnostics, life sciences, platform, testing services

MBio Diagnostics News

MBio Diagnostics Company Life

You may also be interested in